Aims & Scope
Applied In Vitro Toxicology is a peer-reviewed journal providing the latest research on the development, validation and application of new and innovative in vitro testing methods for predicting adverse effects of drugs, chemicals, and products in the pharmaceutical, chemical, or personal care industries. The Journal addresses in depth the issues facing these industries, by including discussions on regulatory requirements; the reduction, refinement, and replacement of animal testing; new screening methods; evaluation of new cell and tissue models; and the most appropriate methods for assessing safety and satisfying regulatory demands.
Applied In Vitro Toxicology endeavors to serve as the foremost journal for researchers focusing on the development and use of in vitro methods to understand the effects of test agents on biological systems. Organizations involved with hazard identification and risk assessment will want to read AIVT in order to understand how new and existing in vitro methods are applied, and the questions for which these models provide answers.
Applied In Vitro Toxicology coverage includes:
- Applied in vitro toxicology industry standards
- New technologies developed for applied in vitro toxicology
- Data acquisition, cleaning, distribution, and best practices
- Data protection, privacy, and policy
- Business interests from research to product
- The changing role of in vitro toxicology
- Visualization and design principles of applied in vitro toxicology infrastructures
- Physical interfaces and robotics
- Opportunities around applied in vitro toxicology
Applied In Vitro Toxicology is under the editorial leadership of Editor-in-Chief Andrew Gow, PhD, DABT, Rutgers University, and Deputy Editor Chantra Eskes, PhD, SeCAM, and other leading researchers. View the entire editorial board.
Audience: Research and developmental scientists; pharmaceutical, veterinary, horticultural, and chemical researchers; toxicologists, product manufacturers, regulators, among others
Submit Your Research
We strongly encourage academic laboratories to submit their work on new methods or using in vitro models to address issues related to cellular or molecular biology. Computational toxicologists are also encouraged to submit their novel modelling and other data to the journal. The Journal actively delivers the latest views and opinions of researchers developing new models, end users of the models, academic laboratories inventing new tools, and regulatory agencies in the United States, Europe, Latin America, Australia, and Asia.
- PubMed Central
- EMBASE/Excerpta Medica
- Chemical Abstracts